{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:44:44Z","timestamp":1790844284972,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12964-015-0086-x","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T09:08:50Z","timestamp":1422868130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism"],"prefix":"10.1186","volume":"13","author":[{"given":"Stefania","family":"Raimondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Flugy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroldo","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"86_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"86_CR2","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1074\/jbc.M111501200","volume":"277","author":"J Sonoyama","year":"2002","unstructured":"Sonoyama J, Matsumura I, Ezoe S, Satoh Y, Zhang X, Kataoka Y, et al. Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR\/ABL in K562 cells. J Biol Chem. 2002;277:8076\u201382.","journal-title":"J Biol Chem"},{"key":"86_CR3","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1182\/blood-2011-05-355396","volume":"120","author":"A Agarwal","year":"2012","unstructured":"Agarwal A, Fleischman AG, Petersen CL, MacKenzie R, Luty S, Loriaux M, et al. Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML. Blood. 2012;120:2658\u201368.","journal-title":"Blood"},{"key":"86_CR4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.cellsig.2012.05.015","volume":"24","author":"PF Seke Etet","year":"2012","unstructured":"Seke Etet PF, Vecchio L, Nwabo Kamdje AH. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment. Cell Signal. 2012;24:1883\u20138.","journal-title":"Cell Signal"},{"key":"86_CR5","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/ijms14035338","volume":"14","author":"C Corrado","year":"2013","unstructured":"Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14:5338\u201366.","journal-title":"Int J Mol Sci"},{"key":"86_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","volume":"348","author":"C Corrado","year":"2014","unstructured":"Corrado C, Raimondo S, Saieva L, Flugy AM, De Leo G, Alessandro R. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an Interleukin 8-dependent survival of leukemia cells. Cancer Lett. 2014;348:71\u20136.","journal-title":"Cancer Lett"},{"issue":"2","key":"86_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-12-2184","volume":"73","author":"J Huan","year":"2013","unstructured":"Huan J, Hornick NI, Skinner AM, Goloviznina NA, Roberts CT, Kurre P. RNA trafficking by acute myeloid leukemia exosomes. Cancer Res. 2013;73(2):918\u201329.","journal-title":"Cancer Res"},{"key":"86_CR8","doi-asserted-by":"publisher","first-page":"e42310","DOI":"10.1371\/journal.pone.0042310","volume":"7","author":"C Corrado","year":"2012","unstructured":"Corrado C, Flugy AM, Taverna S, Raimondo S, Guggino G, Karmali R, et al. Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis. PLoS One. 2012;7:e42310.","journal-title":"PLoS One"},{"key":"86_CR9","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/ijc.26217","volume":"130","author":"S Taverna","year":"2012","unstructured":"Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, et al. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer. 2012;130:2033\u201343.","journal-title":"Int J Cancer"},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.dld.2009.04.006","volume":"41","author":"JL Qu","year":"2009","unstructured":"Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K\/Akt and MAPK\/ERK activation. Dig Liver Dis. 2009;41:875\u201380.","journal-title":"Dig Liver Dis"},{"key":"86_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bcp.2010.03.001","volume":"80","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Settleman J. Exploiting the balance between life and death: targeted cancer therapy and \u201concogenic shock\u201d. Biochem Pharmacol. 2010;80:666\u201373.","journal-title":"Biochem Pharmacol"},{"key":"86_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer. 2010;10:415\u201324.","journal-title":"Nat Rev Cancer"},{"key":"86_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jb\/mvr016","volume":"149","author":"X Zhu","year":"2011","unstructured":"Zhu X, Wang L, Zhang B, Li J, Dou X, Zhao RC. TGF-beta1-induced PI3K\/Akt\/NF-kappaB\/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts. J Biochem. 2011;149:405\u201314.","journal-title":"J Biochem"},{"key":"86_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jb\/mvs106","volume":"152","author":"K Miyazono","year":"2012","unstructured":"Miyazono K. Tumour promoting functions of TGF-beta in CML-initiating cells. J Biochem. 2012;152:383\u20135.","journal-title":"J Biochem"},{"key":"86_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463:676\u201380.","journal-title":"Nature"},{"key":"86_CR16","doi-asserted-by":"publisher","first-page":"e52465","DOI":"10.1371\/journal.pone.0052465","volume":"7","author":"J Gu","year":"2012","unstructured":"Gu J, Qian H, Shen L, Zhang X, Zhu W, Huang L, et al. Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-beta\/Smad pathway. PLoS One. 2012;7:e52465.","journal-title":"PLoS One"},{"key":"86_CR17","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","volume":"67","author":"A Clayton","year":"2007","unstructured":"Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007;67:7458\u201366.","journal-title":"Cancer Res"},{"key":"86_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3727\/096504003108748302","volume":"13","author":"T Suthiphongchai","year":"2003","unstructured":"Suthiphongchai T, Promyart P, Virochrut S, Tohtong R, Wilairat P. Involvement of ERK1\/2 in invasiveness and metastatic development of rat prostatic adenocarcinoma. Oncol Res. 2003;13:253\u20139.","journal-title":"Oncol Res"},{"key":"86_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/030089160409000102","volume":"90","author":"S Brader","year":"2004","unstructured":"Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori. 2004;90:2\u20138.","journal-title":"Tumori"},{"key":"86_CR20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-07-2088","volume":"6","author":"G Sethi","year":"2008","unstructured":"Sethi G, Ahn KS, Aggarwal BB. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008;6:1059\u201370.","journal-title":"Mol Cancer Res"},{"key":"86_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1476-4598-9-97","volume":"9","author":"SS Han","year":"2010","unstructured":"Han SS, Yun H, Son DJ, Tompkins VS, Peng L, Chung ST, et al. NF-kappaB\/STAT3\/PI3K signaling crosstalk in iMyc E mu B lymphoma. Mol Cancer. 2010;9:97.","journal-title":"Mol Cancer"},{"key":"86_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tibs.2013.10.001","volume":"38","author":"L Zhang","year":"2013","unstructured":"Zhang L, Zhou F, ten Dijke P. Signaling interplay between transforming growth factor-beta receptor and PI3K\/AKT pathways in cancer. Trends Biochem Sci. 2013;38:612\u201320.","journal-title":"Trends Biochem Sci"},{"key":"86_CR23","first-page":"3703","volume":"25","author":"K Koga","year":"2005","unstructured":"Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005;25:3703\u20137.","journal-title":"Anticancer Res"},{"key":"86_CR24","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1073\/pnas.0804543106","volume":"106","author":"K Al-Nedawi","year":"2009","unstructured":"Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009;106:3794\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"86_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00262-005-0075-9","volume":"55","author":"M Baj-Krzyworzeka","year":"2006","unstructured":"Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother. 2006;55:808\u201318.","journal-title":"Cancer Immunol Immunother"},{"key":"86_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0092-8674(00)81883-8","volume":"88","author":"TF Franke","year":"1997","unstructured":"Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell. 1997;88:435\u20137.","journal-title":"Cell"},{"key":"86_CR27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.leu.2403653","volume":"19","author":"VL Grandage","year":"2005","unstructured":"Grandage VL, Gale RE, Linch DC, Khwaja A. PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia. 2005;19:586\u201394.","journal-title":"Leukemia"},{"key":"86_CR28","doi-asserted-by":"publisher","first-page":"e39945","DOI":"10.1371\/journal.pone.0039945","volume":"7","author":"AR Hussain","year":"2012","unstructured":"Hussain AR, Ahmed SO, Ahmed M, Khan OS, Al Abdulmohsen S, Platanias LC, et al. Cross-talk between NFkB and the PI3-kinase\/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis. PLoS One. 2012;7:e39945.","journal-title":"PLoS One"},{"key":"86_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1681\/ASN.2012101031","volume":"24","author":"FT Borges","year":"2013","unstructured":"Borges FT, Melo SA, Ozdemir BC, Kato N, Revuelta I, Miller CA, et al. TGF-beta1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol. 2013;24:385\u201392.","journal-title":"J Am Soc Nephrol"},{"key":"86_CR30","doi-asserted-by":"publisher","first-page":"9621","DOI":"10.1158\/0008-5472.CAN-10-1722","volume":"70","author":"J Webber","year":"2010","unstructured":"Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010;70:9621\u201330.","journal-title":"Cancer Res"},{"key":"86_CR31","first-page":"4489","volume":"20","author":"H Saito","year":"2000","unstructured":"Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M, et al. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. Anticancer Res. 2000;20:4489\u201393.","journal-title":"Anticancer Res"},{"key":"86_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0959-8049(02)00502-6","volume":"39","author":"V Ivanovic","year":"2003","unstructured":"Ivanovic V, Todorovic-Rakovic N, Demajo M, Neskovic-Konstantinovic Z, Subota V, Ivanisevic-Milovanovic O, et al. Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression. Eur J Cancer. 2003;39:454\u201361.","journal-title":"Eur J Cancer"},{"key":"86_CR33","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/nrd1580","volume":"3","author":"JM Yingling","year":"2004","unstructured":"Yingling JM, Blanchard KL, Sawyer JS. Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov. 2004;3:1011\u201322.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-015-0086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-015-0086-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-015-0086-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-015-0086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:49:43Z","timestamp":1630554583000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-015-0086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1186\/s12964-015-0086-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]},"assertion":[{"value":"17 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}